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Abstract 
Plumbagin, 3,3’-biplumbagin and 8,8’-bi- 
plumbagin are naphthoquinones isolated by activity-directed 
fractionation from a Bolivian plant, Pera benensis, used in 
folk medicine as treatment of cutaneous leishmaniasis 
caused by Leishmania br-aziliensis. BALB/c mice were in- 
fected with L. mexicana os L. veneziielensis and treated 24 h 
afier the parasitic infection with plumbagin (5 or 2.5 mg/kg 
/tiay), 3,3’-biplumbagin, 8,8’-biplumbagin (25 mg/kg/d) or 
Glucantime’B (200 mg/kg/d). Lesion development was the 
c+fteria employed to evaluate the inhibitory effect. The bis- 
1 hthoqdnones were less potent than Glucantime against q p  atnazonensis and L. venezuelensis. Plumbagin and 
Glucantime delayed the development of L. amazonensis and 
L. venezuelensis. Assays of a single local treatment on foot- 
pad infection two weeks after the parasitic inoculation with 
L. amazonensis showed that 8,8’-biplumbagin (50 mg/kg/d) 
was as potent as Glucantime (400mg/kg/d). 
Introduction 
Cutaneous and mucocutaneous leishmaniasis 
are endemic diseases in the tropical subandean regions. Cu- 
taneous leishmaniasis is popularly known as espundia in the 
arei  of Bolivia called Oriente by the natives. The use of medi- 
6Í.b plants for the specific treatment of cutaneous leishïïania- 
sis, is quite widespread, specially Pera benensis (Euphorbia- 
ce.?;). The fresh stem barks are applied directly on  the lesion. 
We have previously reported the study of the 
chemical identification of active compounds and the leish- 
manial and trypanocidal activities in vitro of three active naph- 
thoquinones (Fig. l), plumbagin, 3,3’-biplumbagin and 8,8’-bi- 
plumbagin (Fournet et al., 1990). These compounds isolated by 
activity-directed fractionation from the stem barks and root 
barks of Pera benensis, displayed activity in vitro at 10pg/ml 
against ‘three strains of promastigote forms of Leishmania spe- 
ci+, L. amazonensis (PH 8 and H-142), L. braziliensis 
(y42903) and L. donovani (2682) and six strains of epimas- 
tigde forms of Trypanosoma cnizi. Plumbagin was also active 
Accepted 13 October 1992 
Med. Parasitol. 43 (1992) 219-222 
O eorg Thieme Verlag Stuttgart. New York + 
O T‘ I I  
(C) 
Fig. 1 Structures of (a) plumbagin; (b) 3,3’-biplumbagin; 
(c) 8,8’-biplumbagin 
against amastigote forms ofL. ainazonensis (PH 8) infecting the 
mouse peritoneal macrophages. 
The aims of this present paper were to evaluate 
the activity of naphthoquinones in BALB/c mice infected with 
i. amazonensis or with L. venezuelensis, two species of Amer- 
ican cutaneous leishmaniasis. We have used L. venezuelensis 
because this parasite produces for the hamster a rapid growing 
granuloma at the site of inoculation, containing abundant 
amastigotes. After a few months, we have observed necrosis on 
the nose and the head of the animal. 
The mouse footpad infection has been used as 
model for these experiments (Avila et al., 1990; Coleman et al., 
1989). 
Materials and  methods 
Animals 
Female or male BALB/c mice were sipplied by 
Charles River Breeding Laboratory and then were bred in IBRA 
(Bolivia). Mice weighed 18-20 g and eight weeks old when bioassays 
were initiated. 
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Fig. 2 Effects of plumbagin (2.5 mg/kg/d) and Glucantime 
(200 mg/kg/d) on the development of L. amazonensis (PH 8) 
in BALBlc mice (n = lo,-/+ S.E.M.). Treatments were given 
for 14 d period commencing 1 d after inoculation of L. amazo- 
nensis S.E.M. = -I+ Standard error of the mean 
Fig. 3 Effects of plumbagin (5 mg/kg/d) and Glucantime 
(200 mg/ kg/d) on the development of L. venezuelensis 
(H-3) in BALB/c mice (n = 6, -/+ SEM). Treatments were 
given for 14 d period commencing 1 d after inculation 
of L. venezuelensis. 
Table 1 Effect of Glucantime (200 mg/kg/d), 3,3'-biplumbagin (25 mg/kg/d), 8,8'-biplumbagin (25 mg/kg/d) on the  development of 
L. amazsnensis (PH 8) in BALB/c mice (-/+SEM). Drug were given for 14 d-period commencing 1 d after inoculation of L. amazonensis. 
Diameter of lesion' 
Weeks post Control'* Glucantime"' 33'- 8,8'- 
biplumbagin*' biplumbagin** infection 
2 0.3 (0.1 5) 0.3 (0.08) 0.5 (0.13) 0.4 (0.11) 
1.4 (0.34) 1 .O8 (0.28) 4 1.6 (0.3) 0.9 (0.23) 
6 3.8 (0.6) 1.7 (0.52) 2. 7 (0.55) 2.6 (0.33) 
8 6.0 (0.88) 3.23 (0.87) 4.58 (0.84) 5.05 (0.62) 
9 6.9 (0.70) 3.66 (1.03) 5.05 (0.83) 5.63 (0.74) 
'Average measurement (in mm) for 8 mice. ** -/+ Standard error of the mean (S.E.M.) 
Leishmania strains 
L. amazonensis (fFLAIBR167IPH 8 )  and L. vene- 
zitelensis (VE/74/PM-H3) were used. The source and history of this 
isolate have been described by Bonfante-Garrido (1983). BALB/c mice 
(n = 10, n = 8 or n = 6) were infected subcutaneously in the right rear 
footpad with 1 X lo6 amastigotes obtained from infected hamsters. The 
parasites were delivered in 200 pl phosphate buffered saline (PBS), 
with control mice receiving PBS only. 
The growth of the lesion was determined weekly by 
measuring the diameter of both rear feet with a direct reading vemier 
caliper (Ref: Kroelin lODI OOT6). The size of lesion in millimeters 
(Index of Leishmaniasis) was calculated by subtracting the measure- 
ments obtained for the uninfected foot from that the infected foot. 
Measurements started one day prior to the inoculation of amastigotes 
and continued for 8 or 9 weeks. 
Dnig treatment 
Two experiments were conducted. Mice in the first 
experiment were treated by subcutaneous route. Glucantime was given 
at a dose of 200mg/kg/4 plumbagin at 5 or 2.5 mglkgld, 3,3'-biplum- 
bagin and 8,8'-biplumbagin at 25 mg/kg/d. Drug treatment started one 
day after the inoculation of amastigotes and continued once daily for 
14 days. 
In the second experiment, mice were treated directly 
on the infected rear footpad with a single dose 14 days after inoculation 
! of parasites. For this experiment, mice were treated with Glucantime at 
.? 
400 mg/kg/d, plumbagin at 10 mg/kg/d, 3,3'-biplumbagin and 8,8'-bi- 
plumbagin at 50 mg/ kg/d. 
The naphthoquinones were dissolved in 40 pl of pol- 
ysorbate (Tween 80, Prolabo). For each experiment was calculated the 
mean and standard error of the mean (S.E.M.). 
Results 
Activity of naphtkoqirinones 
of Leishmania amazonensis 
Separate experiments were conducted in which 
plumbagin was administered at different doses (7.5, 5, and 
2.5mg/kg daily) beginning 24 hr prior to infection with 
L. amazonensis (PH 8).  Mice treated with 7.5mg died within 
four weeks after the beginning of experiment. Figure 2 shows 
the combined results obtained with mice treated with 2.5 mg/kg 
daily of plumbagin compared to mice treated with 200mg/kg 
daily of Glucantime. After eight weeks mice treated with plum- 
bagin or with Glucantime had an average lesion size of Jmm 
compared with 6.8" for control. We did not observe toxic 
effect of plumbagin at 2.5 mg/kg daily. We have obtained the 
same effects when plumbagin was administered at 5 mg/kg. 
Table 1 presents the experiments of treatment 
with bis-naphthoquinones, 3,3'-biplumbagin and 8,8'-biplum- 
bagin. These compounds were less toxic than plumbagin but 
less efficient at 25 mg/kg daily. After nine weeks, mice treated 
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infected with L. amazonensis (LV/78) or L. donovani (LV9). 
A bis-naphthoquinone isolated from the Indian plant, diospy- 
rine, a dimer of 7-methyl-juglone is also active in vitro against 
L. donovani (Hazra et al., 1987). Several authors have reported 
an antiprotozoal activity of naphthoqilinotles (Callahan et ni., 
1988; Pinto et al., 1987; Wright and Phillipson, 1990), particu- 
larly o f  lapachol and ß-lapachone isolated from Tabebuia rosea 
(Bignoniaceae) against Plasmodium falcipanlm (Carvalho et  
al., 1988) and against T'panosoma cruzi (Goncalves et al., 
1980), and a derived of lapachone, lapinone (Hudson et al., 
1985) against Plasmodium v i va .  Recently synthetic naph- 
thoquinones (566CSO) have been described as active against 
Pneumocystis cariniì (Wellcome Foundation, 1990). Several 
authors have described the activity of naphthoquinones against 
skin diseases, plumbagin (Gujar, 1990) and 2-hydroxy- 1,4- 
naphthoquinones for prevention of dermatitis on the scalps 
(Tsucha and Yutaka, 1990). 
In conclusion, the results of this study show 
that treatment with a topical application directly on the lesion 
of leishmaniasis of stem barks of Pera benensìs may be effec- 
tive against leishmaniasis. It could be possible to propose an 
effective ointment prepared locally with a low concentration of 
plumbagin or an other derived of this napthoquinone less toxic 
as 8,8'-biplumbagin. These formulations would be developed in 
endemic regions of cutaneous and mucocutaneous leishmania- 
sis, in particular in areas of colonization of Bolivia when occure 
the lack of usual drugs'as pentavalent antimonials. 
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